Technologies for Cancer Research

USD 950

* Required Fields

USD 950

PAY BY INVOICE

Be the first to review this product

Cancer therapeutics are rapidly evolving with better targets and biologics. The greatest therapeutic current need is present across the indication of cancer. With each individual having a different and more unpredictable form of the disease, the need for personalized medicine is far greater. Hence, novel drug discovery technologies and drug delivery mechanisms are continuously being researched.

The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders.

The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Cancer therapy, biologics, mAbs, antibodies, cancer treatment

Table of Contents

Technologies for Cancer ResearchCancer Research Technology InnovationsThrowing Light on Deprioritized/Under-resourced Anti-Cancer AgentsProgramming Cancer Cell Death through the Neuro-Signaling Approach Introducing Combined Theranostic Approaches in CancerTargeting Chronic Lymphocytic Leukemia through Restoration of Cancer Cell ApoptosisNovel Cancer Therapy for the Treatment of Soft Tissue SarcomaPriority Review from the FDA for a Drug Targeted toward Liver CancerMonotherapy for Newly Diagnosed Multiple Myeloma PatientsCancer Pharmaceuticals Pipeline and Industry InteractionsPipeline AnalysisClinical TrialsIndustry InteractionsIndustry Interactions (Continued)




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.